SCHEMBL4285470

SCHEMBL4285470

CSNC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28417524 0.97
SCHEMBL6142183 0.72
SCHEMBL2011013 0.72
SCHEMBL3585721 0.67
SCHEMBL83632 0.67
SCHEMBL9225235 0.67
SCHEMBL1425039 0.67
Hydrochloric Acid SCHEMBL10504521 0.67
SCHEMBL1535316 0.62
SCHEMBL181641 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109963886-B Phosphoguanidine group IV metal olefin polymerization catalyst 陶氏环球技术有限责任公司 2023-01-06 CN disclosed
CN-109963884-B Doubly-linked phosphaguanidine group IV metal complexes and olefin polymerization catalysts therefrom 陶氏环球技术有限责任公司 2021-11-09 CN disclosed
CN-109963886-A Phospha guanidine IV race metal olefin polymerization catalyst 陶氏环球技术有限责任公司 2019-07-02 CN disclosed
CN-109963884-A Doubly-linked phosphaguanidine group IV metal complexes and olefin polymerization catalysts therefrom 陶氏环球技术有限责任公司 2019-07-02 CN disclosed
US-8735416-B2 Antiviral therapies TECHNISCHE UNIVERSITAET CAROLO-WILHELMINA ZU BRAUNSCHWEIG (DE) 2014-05-27 US disclosed
US-20140113923-A1 NOVEL ANTIVIRAL THERAPIES TECHNISCHE UNIVERSITAET CAROLO-WILHELMINA ZU BRAUNSCHWEIG (DE) 2014-04-24 US disclosed
EP-2484360-A1 Phenylboronic acid compounds as antiviral agents K.U. Leuven Research and Development (BE) 2012-08-08 EP disclosed
US-8193157-B2 Antiviral therapies K.U.LEUVEN RESEARCH & DEVELOPMENT (BE) 2012-06-05 US disclosed
US-20090042793-A1 Novel Antiviral Therapies K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2009-02-12 US disclosed
EP-1937256-A2 ANTIVIRAL THERAPY WITH CARBOHYDRATE BINDING AGENTS K.U. Leuven Research and Development (BE) 2008-07-02 EP disclosed
WO-2007033444-A2 ANTIVIRAL THERAPY WITH CARBOHYDRATE BINDING AGENTS K.U. LEUVEN RESEARCH AND DEVELOPMENT (BE) 2007-03-29 WO disclosed